0001950915-22-000001.txt : 20221017 0001950915-22-000001.hdr.sgml : 20221017 20221017170342 ACCESSION NUMBER: 0001950915-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221017 DATE AS OF CHANGE: 20221017 EFFECTIVENESS DATE: 20221017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Matchpoint Therapeutics Inc. CENTRAL INDEX KEY: 0001950915 IRS NUMBER: 863144282 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-462017 FILM NUMBER: 221314224 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 400 SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-620-6280 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 400 SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001950915 Matchpoint Therapeutics Inc. ONE KENDALL SQUARE BUILDING 400 SUITE 201 CAMBRIDGE MA MASSACHUSETTS 02139 617-620-6280 DELAWARE EoCys Inc. None Corporation true 2021 Andre Turenne c/o Matchpoint Therapeutics Inc. One Kendall Square, Building 400 Ste 201 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Bruce Booth c/o Matchpoint Therapeutics Inc. One Kendall Square, Building 400 Ste 201 Cambridge MA MASSACHUSETTS 02139 Director Jason Hafler c/o Matchpoint Therapeutics Inc. One Kendall Square, Building 400 Ste 201 Cambridge MA MASSACHUSETTS 02139 Director Daniel Becker c/o Matchpoint Therapeutics Inc. One Kendall Square, Building 400 Ste 201 Cambridge MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06b false 2022-10-05 false true false 0 69999990 41999994 27999996 false 15 0 0 0 false Matchpoint Therapeutics Inc. /s/ Andre Turenne Andre Turenne Chief Executive Officer 2022-10-17